Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Abeona Therapeutics Inc (ABEO) – Abeona Therapeutics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Abeona Therapeutics (ABEO) trades at $5.63, down 2.6% on the day. The stock shows a bullish technical signal with strong analyst support (6 Buy, 3 Hold ratings) and has beaten earnings expectations for three consecutive quarters. Fundamentally, the company reported a significant net income of $71.18M for 2025, driven by the commercial launch of its FDA-approved gene therapy ZEVASKYN, though operating cash flow remains negative. Recent news highlights expansion of its treatment center network and pipeline development.
The outlook is cautiously optimistic, centered on ZEVASKYN's commercial execution and pipeline progress. Key opportunities include capturing a multi-billion dollar market for recessive dystrophic epidermolysis bullosa (RDEB) treatment. Primary risks involve the company's ability to achieve sustained revenue growth from a nascent launch, manage high SG&A expenses, and transition to positive operating cash flow in a competitive biopharma landscape.
Read full analysis

Key Stats

  • Market Cap
    $324.59M
  • Sector
    Health
  • 3M Drawdown
    -18.02%
  • Enterprise Value
    $179.49M
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    9 days
$5.68
52W Low: $4.17
11 Nov 2025
52W High: $7.23
22 Aug 2025

Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $324.59M, with an enterprise value of $179.49M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -18.02%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 9 days, indicating typical investor behavior on the platform.

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $324.59M
  • Sector
    Health
  • 3M Drawdown
    -18.02%
  • Enterprise Value
    $179.49M
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    9 days
$5.68
52W Low: $4.17
11 Nov 2025
52W High: $7.23
22 Aug 2025

Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $324.59M, with an enterprise value of $179.49M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -18.02%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 9 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!